ABCL vs DVN · rev $12.4M vs P/E 7.4, rev $7.42B
Abcellera Biologics Inc (ABCL) versus Devon Energy Corporation (DVN) — a side-by-side from cached financials, not a winner call.
Abcellera Biologics Inc (ABCL) is a biotechnology company listed on US.
Devon Energy Corporation (DVN) is a oil & gas e&p company listed on US.
Latest reported ABCL revenue for 2026-06-30 was $12.4M. Net income was -$98.6M. Revenue was up 48.7% from 2026-03-31 to 2026-06-30. ABCL currently screens at market cap $1.12B.
Latest reported DVN revenue for 2026-06-30 was $7.42B. Net income was $1.91B. Revenue was up 94.8% from 2026-03-31 to 2026-06-30. DVN currently screens at market cap $22.42B and trailing P/E 7.4.
ABCL currently screens at market cap $1.12B. DVN currently screens at market cap $22.42B and trailing P/E 7.4.
Not investment advice. Open the ABCL and DVN stock pages for the full models.
Not investment advice.